Skip to main content
Log in

Bacterial pericarditis requires antibacterial therapy tailored to the causative organism and patient

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Table II
Table III

References

  1. Pankuweit S, Ristić AD, Seferović PM et al. Bacterial pericarditis: diagnosis and management. Am J Cardiovasc Drugs 2005; 5(2): 103–12

    Article  PubMed  Google Scholar 

  2. Rubin RH, Moellering Jr RC. Clinical, microbiologic and therapeutic aspects of purulent pericarditis. Am J Med 1975; 59(1): 68–78

    Article  PubMed  CAS  Google Scholar 

  3. Klacsmann PG, Bulkley BH, Hutchins GM. The changed spectrum of purulent pericarditis: an 86 year autopsy experience in 200 patients. Am J Med 1977; 63: 666–73

    Article  PubMed  CAS  Google Scholar 

  4. Keersmaekers T, Elshot SR, Sergeant PT. Primary bacterial pericarditis. Acta Cardiol 2002; 57(5): 387–9

    Article  PubMed  Google Scholar 

  5. Spodick DH. Infectious pericarditis. In: Spodick DH, editor. The pericardium: a comprehensive textbook. New York: Marcel Dekker, 1997: 260–90

    Google Scholar 

  6. Brook I. Pericarditis due to anaerobic bacteria. Cardiology 2002; 97(2): 55–8

    Article  PubMed  CAS  Google Scholar 

  7. Sagrista-Sauleda J, Barrabes JA, Permanyer-Miralda G, et al. Purulent pericarditis: review of a 20-year experience in a general hospital. J Am Coll Cardiol 1993; 22: 1661–5

    Article  PubMed  CAS  Google Scholar 

  8. Miller WI, Osborn MJ, Sinak LJ, et al. Pyopneumopericardium attributed to an esophagopericardial fistula: report of a survivor and review of the literature. Mayo Clin Proc 1991; 66: 1041–5

    Article  PubMed  CAS  Google Scholar 

  9. Permanyer-Miralda G, Sagrista-Sauleda J, Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients. Am J Cardiol 1985; 56: 623–30

    Article  PubMed  CAS  Google Scholar 

  10. Fowler NO. Tuberculous pericarditis. JAMA 1991; 266(1): 99–103

    Article  PubMed  CAS  Google Scholar 

  11. Goodman LJ. Purulent pericarditis. Curr Treat Options Cardiovasc Med 2000; 2(4): 343–50

    Article  PubMed  Google Scholar 

  12. Martineau AR, Beeching NJ, Nye FJ, et al. Serum and pericardial fluid bactericidal assays in a patient with staphylococcal pericarditis. J Infect 2001; 43(2): 158–9

    Article  PubMed  CAS  Google Scholar 

  13. Scheid WM, Sande MA. Endocarditis and intravascular infections. In: Mandell GL, Bennett JE, Dolin R, editors. Mandel, Douglas and Bennett’s principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995: 740–56

    Google Scholar 

  14. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR Recomm Rep 1994; 43(RR13): 1–132

    Google Scholar 

  15. Mayosi BM, Ntsekhe M, Volmink JA, et al. Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev 2002; (4): CD000526

  16. Centers for Disease Control and Prevention. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. MMWR Morb Mortal Wkly Rep 1998; 47(RR-20): 1–51

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bacterial pericarditis requires antibacterial therapy tailored to the causative organism and patient. Drugs Ther. Perspect 21, 7–9 (2005). https://doi.org/10.2165/00042310-200521090-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200521090-00003

Navigation